MUTATIONS IN THE NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 2A AND CORRELATION WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY

被引:0
|
作者
Hayashi, Kazuhiko [1 ]
Katano, Yoshiaki [1 ]
Ishigami, Masatoshi [1 ]
Nakano, Isao [1 ]
Goto, Hidemi [1 ]
机构
[1] Nagoya Univ, Nagoya, Aichi 4648601, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
796
引用
收藏
页码:677A / 677A
页数:1
相关论文
共 50 条
  • [31] Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy
    Pascal Veillon
    Christopher Payan
    Hélène Le Guillou-Guillemette
    Catherine Gaudy
    Franoise Lunel
    World Journal of Gastroenterology, 2007, (08) : 1195 - 1203
  • [32] Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection
    Nakagawa, Mina
    Sakamoto, Naoya
    Ueyama, Mayumi
    Mogushi, Kaoru
    Nagaie, Satoshi
    Itsui, Yasuhiro
    Azuma, Seishin
    Kakinuma, Sei
    Tanaka, Hiroshi
    Enomoto, Nobuyuki
    Watanabe, Mamoru
    JOURNAL OF GASTROENTEROLOGY, 2010, 45 (06) : 656 - 665
  • [33] Mutagenic effect of ribavirin in NS5A and NS5B regions and response to interferon/ribavirin combination therapy in patients with chronic hepatitis C
    Asahina, Y
    Izumi, N
    Ueda, K
    Inoue, K
    Nishimura, Y
    Tsuchiya, K
    Hamano, K
    Itakura, J
    Noguchi, O
    Uchihara, M
    Miyake, S
    Enomoto, N
    Watanabe, M
    GASTROENTEROLOGY, 2003, 124 (04) : A777 - A777
  • [34] DIFFERENTIAL EFFECT OF PEGYLATED INTERFERON alpha 2a AND alpha 2b ON THE EARLY HEPATITIS C VIRUS KINETICS
    Durante-Mangoni, E.
    Pinto, D.
    Battimelli, C.
    Farinaro, V.
    Savinelli, C.
    Senese, A.
    Iorio, V.
    Graziano, C.
    Iossa, D.
    Molaro, R.
    Sodano, G.
    Utili, R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S333 - S333
  • [35] Response to pegylated interferon α-2b and ribavirin in children with chronic hepatitis C
    Baker, Robert D.
    Dee, Deborah
    Baker, Susan S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (01) : 111 - 114
  • [36] Mutational diversity of NS5A and NS3 during triple therapy (telaprevir, pegylated-interferon-α 2b and ribavirin) for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group
    Bai, Fugui
    Yano, Yoshihiko
    Kim, Soo-Ryang
    Seo, Yasushi
    Miki, Akira
    Saito, Masaya
    Hirano, Hirotaka
    Momose, Kenji
    Minami, Akihiro
    Hatazawa, Yuri
    Hayakumo, Takanobu
    Widasari, Dewiyani Indah
    Rinonce, Hanggoro Tri
    Sugano, Masahiko
    Tani, Satoshi
    Yoon, Seitetsu
    Imoto, Susumu
    Azuma, Takeshi
    Hotta, Hak
    Hayashi, Yoshitake
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (06) : 1652 - 1656
  • [37] Pegylated interferon α-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C:: a systematic review and economic evaluation
    Shepherd, J
    Brodin, H
    Cave, C
    Waugh, N
    Price, A
    Gabbay, J
    HEALTH TECHNOLOGY ASSESSMENT, 2004, 8 (39) : 1 - +
  • [38] Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy
    El-Shamy, Ahmed
    Shoji, Ikuo
    Saito, Takafumi
    Watanabe, Hisayoshi
    Ide, Yoshi-Hiro
    Deng, Lin
    Kawata, Sumio
    Hotta, Hak
    MICROBIOLOGY AND IMMUNOLOGY, 2011, 55 (06) : 418 - 426
  • [39] Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus
    Hashimoto, Yuki
    Kanto, Hiromi
    Itoh, Masatoshi
    JOURNAL OF DERMATOLOGY, 2007, 34 (08): : 577 - 582
  • [40] Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients
    Samia Afzal
    Muhammad Idrees
    Madiha Akram
    Zunaira Awan
    Bushra Khubaib
    Mahwish Aftab
    Zareen Fatima
    Sadaf Badar
    Abrar Hussain
    Virology Journal, 7